Smarter Partnering for First Time Success

R&D Without the Risk

We are a partner for generic and specialty pharma, focused on Generics, VAMs and NCEs, with 60+ scientists providing custom developments, advanced formulations and HPAPI-capable services across a wide range of development needs.

  • You are planning to expand your R&D pipeline but internal capacity or expertise is limited. 
  • You face high risk with first-time development projects or have an empty development pipeline.  
  • You want to understand when to keep work in-house vs. when to partner. 
  • You are exploring co-development or risk-sharing models but lack a clear framework. 

The Reality of Scaling Complex Molecules 

The transition from R&D to commercial production is where the most promising programs often stall, not due to the science, but due to execution gaps. Working with siloed partners leads to analytical rework, regulatory delays, and missed market windows. 

The Challenge: Expanding R&D Without Increasing Risk

As your portfolio grows, so do the demands on your R&D organisation. The key challenge is to expand capacity and capabilities through outsourcing and partnerships, without increasing technical, regulatory or financial risk.  

  • Early feasibility and risk assessments guided by experienced scientists 
  • Formulation and process development in a GMPlike setting that mirrors commercial reality 
  • EU GMP analytical support, stability studies and QbD-based design to anticipate downstream hurdles 

Ready to learn more? 

Why Partner with Our Athens Site

Integrated R&D and Production

Our Athens Center of Excellence eliminates silos. We develop with “scalability-first” mindset, ensuring a frictionless transfer to commercial manufacturing.

Mastery of Complexity

Our expertise lies in overcoming unconventional and demanding formulation hurdles.

Regulator-Ready Quality

Quality is embedded, not added. Our GMP systems and product testing are designed to meet the strictest EMA and FDA inspections.

Full Regulatory Support

We are more than a partner, we guide. From bioequivalence strategies to dossier support, we accelerate your path to approval.

  • Formulation and process development in a GMP-like environment
  • Analytical development, GMP testing and stability studies (EU GMP, FDA-ready)
  • Quality by Design (QbD) and systematic risk assessment
  • HPAPI and complex / niche small-molecule projects
  • Regulatory support for generics, VAMs and NCEs
  • Tech transfer and collaboration with manufacturing partners (Our network and CMOs)

Subscribe to our newsletter!

Get notified on our latest news.